TY - JOUR
T1 - Brominated flame retardants effect in MCF-7 cells
T2 - Impact on vitamin D pathway
AU - Sousa, Sara
AU - Maia, Maria Luz
AU - Pestana, Diogo
AU - Teixeira, Diana
AU - Ângelo-Dias, Miguel
AU - Martins, Catarina
AU - Borrego, Luís Miguel
AU - Delerue-Matos, Cristina
AU - Calhau, Conceição
AU - Fernandes Domingues, Valentina
AU - Faria, Ana
N1 - Funding Information:
Sara Sousa and Maria Luz Maia are grateful to FCT and ESF (European Social Fund) through POCH (Programa Operacional Capital Humano) for the Ph.D. grants (SFRH/BD/137516/2018 and SFRH/BD/128817/2017, respectively). The work was supported by UIDB/50006/2020 and UIDP/50006/2020 , CHRC ( UIDB/04923/2020 and UIDP/04923/2020 ) with funding from FCT/MCTES through PT national funds.
Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/5
Y1 - 2022/5
N2 - Brominated flame retardants (BFRs) are persistent environmental pollutants, allowing a constant human exposure which carries several health risks, including the occurrence of breast cancer and vitamin D deficiency. Vitamin D inhibits cell growth and is negatively associated with breast cancer risk. The effect of BFRs in breast cancer and vitamin D pathway is still poorly understood. MCF-7 cells were treated with hexabromocyclododecane (HBCD), 2-ethylhexyl-2,3,4,5-tetrabromobenzoate (TBB), hexabromobenzene (HBB) and pentabromotoluene (PBT) using short and long-term exposure protocols. Viability, proliferation, migration, cell cycle and gene expression were assessed. Gene expression of hVDBP and hCYP2R1 was also evaluated in hepatocytes. Long-term exposure of MCF-7 cells to HBB increased cell proliferation and migration, consequently increasing MMP-9 expression. The vitamin D pathway was also altered by BFRs: cells appeared less prepared to activate and transport vitamin D and the signaling, action and inactivation mechanisms were diminished in the presence of BFRs. Untreated MCF-7 cells showed cell cycle arrest in phase G0/G1 in the presence of activated vitamin D. However, when MCF-7 cells were exposed to BFRs, cell cycle was arrested in phase G2/M, possibly due to DNA damage. Nonetheless, calcitriol seems to be able to mitigate the effect of some BFRs exposure, e.g. PBT.
AB - Brominated flame retardants (BFRs) are persistent environmental pollutants, allowing a constant human exposure which carries several health risks, including the occurrence of breast cancer and vitamin D deficiency. Vitamin D inhibits cell growth and is negatively associated with breast cancer risk. The effect of BFRs in breast cancer and vitamin D pathway is still poorly understood. MCF-7 cells were treated with hexabromocyclododecane (HBCD), 2-ethylhexyl-2,3,4,5-tetrabromobenzoate (TBB), hexabromobenzene (HBB) and pentabromotoluene (PBT) using short and long-term exposure protocols. Viability, proliferation, migration, cell cycle and gene expression were assessed. Gene expression of hVDBP and hCYP2R1 was also evaluated in hepatocytes. Long-term exposure of MCF-7 cells to HBB increased cell proliferation and migration, consequently increasing MMP-9 expression. The vitamin D pathway was also altered by BFRs: cells appeared less prepared to activate and transport vitamin D and the signaling, action and inactivation mechanisms were diminished in the presence of BFRs. Untreated MCF-7 cells showed cell cycle arrest in phase G0/G1 in the presence of activated vitamin D. However, when MCF-7 cells were exposed to BFRs, cell cycle was arrested in phase G2/M, possibly due to DNA damage. Nonetheless, calcitriol seems to be able to mitigate the effect of some BFRs exposure, e.g. PBT.
KW - 2-ethylhexyl-2,3,4,5-tetrabromobenzoate
KW - Breast cancer
KW - Calcitriol
KW - Hexabromobenzene
KW - Hexabromocyclododecane
KW - Pentabromotoluene
UR - http://www.scopus.com/inward/record.url?scp=85124323212&partnerID=8YFLogxK
U2 - 10.1016/j.jsbmb.2022.106079
DO - 10.1016/j.jsbmb.2022.106079
M3 - Article
C2 - 35143981
AN - SCOPUS:85124323212
SN - 0960-0760
VL - 219
JO - Journal of Steroid Biochemistry and Molecular Biology
JF - Journal of Steroid Biochemistry and Molecular Biology
M1 - 106079
ER -